Removal of citrate from PAS‐III additive solution improves functional and biochemical characteristics of buffy‐coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction-Reference-Cited by-同舟云学术

Removal of citrate from PAS‐III additive solution improves functional and biochemical characteristics of buffy‐coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction

Published:2021-02 Issue:3 Volume:61 Page:919-930
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Isola Hervé¹,Ravanat Catherine¹^ORCID,Rudwill Floriane¹,Pongerard Anais¹,Haas Delphine¹,Eckly Anita¹,Gachet Christian¹^ORCID,Hechler Béatrice¹^ORCID

Affiliation:

1. INSERM, Etablissement Français du Sang (EFS) Grand Est, BPPS UMR_S 1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS) Université de Strasbourg Strasbourg France

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16280

Reference30 articles.

1. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

2. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

3. The platelet storage lesion

4. Apoptotic activity in stored human platelets

5. In vitro evaluation of stored platelets: Is there hope for predicting posttransfusion platelet survival and function?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy;Transfusion;2024-07-12

2. In vitro Hemostatic Functions of Cold-Stored Platelets;Transfusion Medicine and Hemotherapy;2023-11-16

3. Citrate Phosphate Dextrose Alters Coagulation Dynamics Ex Vivo;Journal of Surgical Research;2023-11

4. Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT ^TMBlood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience;BLOOD TRANSFUS-ITALY;2023

5. Biochemical and functional characteristics of stored (double‐dose) buffy‐coat platelet concentrates treated with amotosalen and a prototype UVA light‐emitting diode illuminator;Transfusion;2023-08-24